Literature DB >> 31106109

Analysis of Clostridium cluster XI bacteria in human feces.

Yuji Ohashi1, Tomohiko Fujisawa1.   

Abstract

Six species and one group of Clostridium cluster XI, Clostridium sordellii, Clostridium bifermentans, Clostridium difficile, Clostridium hiranonis, Intestinibacter bartlettii, and Romboutsia lituseburensis and the Terrisporobacter glycolicus group, respectively, in human feces collected from 18 healthy adults were analyzed with real-time PCR. Although individual differences were recognized, the predominant colonization of C. sordellii and I. bartlettii in the human large intestine was identified.

Entities:  

Keywords:  Clostridium cluster XI; human feces; real-time PCR

Year:  2018        PMID: 31106109      PMCID: PMC6502712          DOI: 10.12938/bmfh.18-023

Source DB:  PubMed          Journal:  Biosci Microbiota Food Health        ISSN: 2186-3342


Clostridia are among the predominant bacteria in the human large intestine. This genus is divided into 19 clusters according to phylogenetic analysis of the 16S rRNA gene [1]. Based on this analysis, many of the bacteria phylogenetically related to Clostridium in the human large intestine belong to Clostridium clusters I, IV, XI, XIVa, and XVI. It was suggested that a high intake of carbohydrates, fat, and protein was associated with increasing amounts of Clostridium cluster XI bacteria in the feces of patients with type 2 diabetes mellitus [2]. Furthermore, it was suggested that the stimulation of Clostridium cluster XI in the feces of mice resulting from feeding of a high-fat diet was associated with development of hepatocellular carcinoma due to the increase of deoxycholic acid produced by the 7α-dehydroxylation enzyme derived from Clostridium cluster XI bacteria [3]. Thus, Clostridium cluster XI should be one of the important harmful bacteria in the large intestine. It is, however, unclear which Clostridium cluster XI bacteria induce the development of hepatocellular carcinoma. Within Clostridium cluster XI, Clostridium difficile, which was reclassified as Clostridioides difficile [4]; Clostridium sordellii, and Clostridium bifermentans are well-known bacterial species in the human large intestine. C. difficile is known to cause antibiotic-associated diarrhea and pseudomembranous colitis [5]. C. sordellii and C. bifermentans have 7α-dehydroxylating activity, which is associated with carcinogenesis [6]. In addition, Clostridium hiranonis, which also has 7α-dehydroxylating activity, was identified from human feces [7]. Secondary bile acids produced by the 7α-dehydroxylation enzyme are suspected of being carcinogens in colorectal cancer. Therefore, C. sordellii, C. bifermentans, and C. hiranonis have been recognized as harmful bacteria. Within Clostridium cluster XI, Clostridium bartlettii, Clostridium glycolicum, and Clostridium lituseburense, which were reclassified as Intestinibacter bartlettii, Terrisporobacter glycolicus, and Romboutsia lituseburensis, respectively [8], were also identified from human feces [9, 10]. It is important to identify which species within Clostridium cluster XI inhabit the human large intestine. In this study, we analyzed C. difficile, C. sordellii, C. bifermentans, C. hiranonis, R. lituseburensis, I. bartlettii, and T. glycolicus using real-time PCR to reveal the composition of Clostridium cluster XI bacteria in human feces. Eighteen fecal samples collected from 16 female and 2 male healthy volunteers age 21–22 were analyzed. The volunteers consumed nonspecific Japanese diets and took no antibiotics for one month prior to fecal collection. This study was approved by the Nippon Veterinary Life Science University Ethics Committee and was performed in accordance with the Helsinki Declaration as updated in Brazil in 2013. The details of this study were explained to all volunteers. An informed consent agreement was obtained from all volunteers before the experiment. Bacterial DNA was extracted from 0.1 g of feces in accordance with the methods of Godon et al. [11]. Primers for C. hiranonis, R. lituseburensis, I. bartlettii, and T. glycolicus were designed. The specificities of these primers were verified with the BLAST provided by the DNA Data of Bank of Japan and the sequencing of PCR products amplified by these primers. For direct sequencing of PCR products, PCR was done with the following conditions: 25 µl of GoTaq (Promega, Tokyo, Japan), 400 µmol/l of each primer, and 2 µl of extracted bacterial DNA in a total volume of 50 µl. Three fecal bacterial DNA were randomly selected from eighteen samples for one primer set, except for C. hiranois primers. For C. hiranois primers, one fecal bacterial DNA was used for PCR, because PCR products were obtained from only one sample. The thermal program consisted of an initial denaturation at 95°C for 2 min, followed by 30 cycles of at 95°C for 30 sec, primer annealing at optimum temperature for 30 sec and at 72°C for optimum elongation length, and final elongation at 72°C for 5 min. The optimum temperature and elongation length of each primer set are given in Table 1. PCR products were purified with the Wizard SV Gel and PCR Clean-Up System (Promega) and subjected to sequencing (Eurofins Genomics, Tokyo, Japan). The obtained sequences were subjected to BLAST search. As shown in Table 2, the sequences of PCR products used with primers for C. hiranonis, R. lituseburensis, and I. bartlettii were related to C. hiranonis [JF693906], R. lituseburensis [MF988703], and Clostridium bartlettii [AY438672], respectively, with 99% or 100% similarities. These results indicated that these primers were effective for the detection of their target bacteria. The sequences of PCR products used with primers for T. glycolicus were related to C. glycolicum [X7650] and Clostridium mayombei [FR733682], which was reclassified as Terrisporobacter mayombei with 99% similarity. Therefore, the target of primers for T. glycolicus was evaluated as the T. glycolicus group in this study. However, there are no reports to our knowledge indicating that T. mayombei has been found in human feces. We considered that T. glycolicus might be effectively detected in human feces by PCR using the primer for T. glycolicus.
Table 1.

Primers used in the present study

TargetPrimerSequence (5’ – 3’)Annealing (˚C) / elongation (sec)Reference
Clostridium cluster XIClostXI-FACGGTACTTGAGGAGGA53 / 15[12]
ClostXI-RGAGCCGTAGCCTTTCACT

C. sordelliiCLSOR-FTCGAGCGACCTTCGG54 / 60[13]
CLSOR-RCACCACCTGTCACCAT

C. bifermentansCLBIF-FCAAGTCGAGCGATCTCT59 / 30[13]
CLBIF-RCCTGCACTCAAGTTCTCT

C. difficileCLDIF-FCTTGAATATCAAAGGTGAGCCA54 / 60[13]
CLDIF-RCTACAATCCGAACTGAGAGTA

C. hiranonisChira-FGTAAGCTCCTGATACTGTCT50 / 25This study
Chira-RGGGAAAGAGGAGATTAGTCC

I. bartlettiiCbart-FGTAAGCTCTTGAAACTGGAG59 / 25This study
Cbart-RGAAAGATGCGATTAGGCATC

T. glycolicus Cgly-F2AAGCTCCGGCGGTATGA54 / 35This study
Cgly-R3CTCTCCTGCACTCAAGTCTC

R. lituseburensisClitu-FTGACATCCTTTTGACCTCTC54 / 35This study
Clitu-RGCCTCACGACTTGGCTG
Table 2.

Identification of PCR products derived from PCR using primers designed in this study

PrimersClosest relative [GenBank accession number]Identity (%)
Chira-F, Chira-RC. hiranonis [JF693906]99
Clitu-F, Clitu-R R. lituseburensis [MF988703]100
R. lituseburensis [MF988703]100
R. lituseburensis [MF988703]100
Cgly-F2, Cgly-R3C. glycolicum1) [X76750] / C. mayombei2) [FR733682]99
C. glycolicum [X76750] / C. mayombei [FR733682]99
C. glycolicum [X76750] / C. mayombei [FR733682]99
Cbart-F, Cbart-RC. bartlettii3) [AY438672]99
C. bartlettii [AY438672]100
C. bartlettii [AY438672]100

1)C. glycolicum is currently classified as T. glycolicus.

2)C. mayombei is currently classified as T. mayombei.

3)C. bartlettii is currently classified as I. bartlettii.

1)C. glycolicum is currently classified as T. glycolicus. 2)C. mayombei is currently classified as T. mayombei. 3)C. bartlettii is currently classified as I. bartlettii. Using these and previously reported primers [12, 13], the 16S rRNA genes of C. difficile, C. sordellii, C. bifermentans, C. hiranonis, R. lituseburensis, I. bartlettii, T. glycolicus group, and Clostridium cluster XI were quantified via real-time PCR. Real-time PCR was performed using a MyiQ real-time PCR system (Bio-Rad, Tokyo, Japan). The reaction mixture (20 µl) contained 10 µl of the SsoAdvanced Universal SYBR Green Supermix (Bio-Rad), 0.5 µl of fecal DNA, and 400 µmol/l of each primer. The primers used in this study are listed in Table 1. The thermal program consisted of initial denaturation at 95°C for 3 min, followed by 40 cycles of at 95°C for 10 sec, primer annealing at the optimum temperature for 30 sec and at 72°C for the optimum elongation length, and final elongation at 72°C for 5 min. The optimum temperature and elongation length of each primer set are given in Table 1. The fluorescent products were detected in the last step of each cycle. A melting-curve analysis of the product was performed after completion of the amplifications to determine the specificity of the PCR. A plasmid containing a partial sequence of the 16S rRNA gene identical to the targeted bacteria was constructed in our laboratory and used as a standard DNA for the real-time PCR. This research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors. Clostridium cluster XI was detected in all subjects, with the log10 copy number of rRNA gene/g of feces ranging from 8.57 to 10.02. There was a large individual difference in the number of Clostridium cluster XI bacteria colonizing in the human large intestine. Although the number of Clostridium cluster XI in the human large intestine may be less than the number of predominant bacteria, such as Bifidobacterium, Bacteroides, and Clostridium cluster XIVa [9], in the human large intestine, it was considered that Clostridium cluster XI should be one of the bacterial group constructing the human large intestinal microbiota. Since Clostridium cluster XI might be undesirable for host health as mentioned above, it is more important to clarify which species in Clostridium cluster XI are present in the human large intestine. The number of species among seven targeted Clostridium cluster XI bacteria detected in a subject ranged from 3 to 5. Four species of Clostridium cluster XI were detected in a subject on average. C. sordellii was detected in all subjects and showed the highest number of 16S rRNA genes (Table 3). I. bartlettii was also detected in all subjects. The detection rates of C. bifermentans, C. hiranonis, R. lituseburensis, and T. glycolicus group were 77.8, 5.6, 33.3, and 44.4%, respectively. The copy numbers of the 16S rRNA gense of C. bifermentans, R. lituseburensis, and T. glycolicus were 100 to 1,000 times lower than those of C. sordellii and I. bartlettii. Although the copy number of the 16S rRNA gene of C. hiranonis was higher than those of C. sordellii and I. bartlettii, C. hiranonis was detected in only one subject. These results suggested that C. sordellii and I. bartlettii, particularly C. sordellii, might be predominant Clostridium cluster XI bacterial species colonizing the human large intestine. C. sordellii could be considered one of the important harmful bacteria in human large intestinal microbiota associated with carcinogenesis, since this bacterium has 7α-dehydroxylating activity, as mentioned above.
Table 3.

Detection of the 16S rRNA gene of Clostridium cluster XI bacteria in human feces

BacteriaNumber of 16S rRNA genes (log copy number of 16S rRNA gene/g of feces)Number of detective subjects (%)
Clostridium cluster XI9.43 ± 0.4218 (100)
C. sordellii8.84 ± 0.4018 (100)
I. bartlettii8.17 ± 0.8618 (100)
C. bifermentans6.68 ± 0.4414 (77.8)
T. glycolicus group6.42 ± 0.788 (44.4)
R. lituseburensis6.14 ± 0.876 (33.3)
C. hiranonis9.561 (5.6)

16S rRNA gene values are the means ± SD.

16S rRNA gene values are the means ± SD. On the other hand, C. difficile was not detected in all subjects. Low colonization of C. difficile in healthy adults has been reported [5, 14, 15]. Moreover, in most cases, the number of C. difficile in healthy adult feces was lower than 104 cfu/g [14, 16]. Thus, it has been shown that C. difficile is poorly colonized in the large intestine of most healthy young adults [5, 15]. To detect target bacteria via PCR, more than 105 cells/g of feces is required due to the sensitivity of the PCR [17]. Therefore, in most healthy young adults, it might be difficult to detect C. difficile in feces using real-time PCR . In this study, the number of C. difficile in the feces of all subjects may have been below the detection limit (104 cfu/g of feces). This might be also true for the case in which C. bifermentans, C. hiranonis, R. lituseburensis, and T. glycolicus group were not detected. In particular, it was suggested that detection of C. hiranonis by PCR was difficult due to the population of C. hiranonis being small even if the bacterium colonized in the large intestine [18]. Kubota et al. reported that TaqMan-based qPCR can detect C. difficile at 103 cfu/g of feces [16]. Small numbers of bacteria were effectively analyzed via RNA-targeted reverse transcription-PCR [17]. To detect these minor bacteria in feces, further studies using these methods are necessary. The copy number of the 16S rRNA gene of Clostridium cluster XI was approximately equal to the sum of those of each analyzed species, except in 2 subjects. This suggested that C. sordellii, I. bartlettii, C. bifermentans, C. hiranonis, R. lituseburensis, and T. glycolicus group might contribute to the composition of Clostridium cluster XI microbiota in the large intestine of young adults. However, in the abovementioned 2 subjects, the copy number of the 16S rRNA gene of Clostridium cluster XI was more than 10 times larger than the sum of those of each analyzed species. This suggested that the other bacterial species belonging to Clostridium cluster XI might colonize in the large intestine. The colonization of Clostridium ghonii, Clostridium irregulare, and Eubacterium tenue, which belong to Clostridium cluster XI, in human feces was previously reported [9]. These bacteria may also be members of the indigenous bacteria comprising Clostridium cluster XI microbiota in the human large intestine. Although not all species of Clostridium cluster XI bacteria were analyzed, we could analyze the composition of Clostridium cluster XI in the human large intestine in detail using real-time PCR. In this study, the individual differences in the numbers and kinds of bacterial species of Clostridium cluster XI were recognized. In addition, the predominant colonization of C. sordellii and I. bartlettii in the large intestine of young adults was identified. Analyses of each bacterial species of Clostridium cluster XI in the human large intestine as in this experiment could provide further detail and effectively clarify the relationship between Clostridium cluster XI bacteria and host health.
  8 in total

1.  New Lactiplantibacillus plantarum and Lacticaseibacillus rhamnosus strains: well tolerated and improve infant microbiota.

Authors:  Gunilla Önning; Ragnhild Palm; Caroline Linninge; Niklas Larsson
Journal:  Pediatr Res       Date:  2021-08-24       Impact factor: 3.953

2.  Culture dependent and independent analyses suggest a low level of sharing of endospore-forming species between mothers and their children.

Authors:  Ekaterina Avershina; Marte Gro Larsen; Marina Aspholm; Toril Lindback; Ola Storrø; Torbjørn Øien; Roar Johnsen; Knut Rudi
Journal:  Sci Rep       Date:  2020-02-04       Impact factor: 4.379

Review 3.  Could the COVID-19-Driven Increased Use of Ivermectin Lead to Incidents of Imbalanced Gut Microbiota and Dysbiosis?

Authors:  Leon M T Dicks; Shelly M Deane; Matthew J Grobbelaar
Journal:  Probiotics Antimicrob Proteins       Date:  2022-02-25       Impact factor: 5.265

4.  Paeniclostridium sordellii hemorrhagic toxin targets TMPRSS2 to induce colonic epithelial lesions.

Authors:  Xingxing Li; Liuqing He; Jianhua Luo; Yangling Zheng; Yao Zhou; Danyang Li; Yuanyuan Zhang; Zhenrui Pan; Yanyan Li; Liang Tao
Journal:  Nat Commun       Date:  2022-07-26       Impact factor: 17.694

Review 5.  The Role of Cyclomodulins and Some Microbial Metabolites in Bacterial Microecology and Macroorganism Carcinogenesis.

Authors:  Natalia N Markelova; Elena F Semenova; Olga N Sineva; Vera S Sadykova
Journal:  Int J Mol Sci       Date:  2022-10-03       Impact factor: 6.208

6.  Dynamics of dark fermentation microbial communities in the light of lactate and butyrate production.

Authors:  Anna Detman; Daniel Laubitz; Aleksandra Chojnacka; Pawel R Kiela; Agnieszka Salamon; Albert Barberán; Yongjian Chen; Fei Yang; Mieczysław K Błaszczyk; Anna Sikora
Journal:  Microbiome       Date:  2021-07-14       Impact factor: 14.650

7.  Microbiome Changes in Humans with Parkinson's Disease after Photobiomodulation Therapy: A Retrospective Study.

Authors:  Brian Bicknell; Ann Liebert; Craig S McLachlan; Hosen Kiat
Journal:  J Pers Med       Date:  2022-01-05

8.  Structural and quantitative alterations of gut microbiota in experimental small bowel obstruction.

Authors:  Jiali Mo; Lei Gao; Nan Zhang; Jiliang Xie; Donghua Li; Tao Shan; Liuyang Fan
Journal:  PLoS One       Date:  2021-08-04       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.